Suppr超能文献

用于保存生育能力的男性生殖干细胞的先进生物工程技术。

Advanced bioengineering of male germ stem cells to preserve fertility.

作者信息

Eyni Hossein, Ghorbani Sadegh, Nazari Hojjatollah, Hajialyani Marziyeh, Razavi Bazaz Sajad, Mohaqiq Mahdi, Ebrahimi Warkiani Majid, Sutherland Duncan S

机构信息

Department of Anatomical Sciences, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark.

出版信息

J Tissue Eng. 2021 Nov 29;12:20417314211060590. doi: 10.1177/20417314211060590. eCollection 2021 Jan-Dec.

Abstract

In modern life, several factors such as genetics, exposure to toxins, and aging have resulted in significant levels of male infertility, estimated to be approximately 18% worldwide. In response, substantial progress has been made to improve in vitro fertilization treatments (e.g. microsurgical testicular sperm extraction (m-TESE), intra-cytoplasmic sperm injection (ICSI), and round spermatid injection (ROSI)). Mimicking the structure of testicular natural extracellular matrices (ECM) outside of the body is one clear route toward complete in vitro spermatogenesis and male fertility preservation. Here, a new wave of technological innovations is underway applying regenerative medicine strategies to cell-tissue culture on natural or synthetic scaffolds supplemented with bioactive factors. The emergence of advanced bioengineered systems suggests new hope for male fertility preservation through development of functional male germ cells. To date, few studies aimed at in vitro spermatogenesis have resulted in relevant numbers of mature gametes. However, a substantial body of knowledge on conditions that are required to maintain and mature male germ cells in vitro is now in place. This review focuses on advanced bioengineering methods such as microfluidic systems, bio-fabricated scaffolds, and 3D organ culture applied to the germline for fertility preservation through in vitro spermatogenesis.

摘要

在现代生活中,诸如遗传、接触毒素和衰老等多种因素导致了男性不育问题严重,据估计全球范围内男性不育率约为18%。作为回应,在改善体外受精治疗方面取得了重大进展(例如显微外科睾丸精子提取术(m-TESE)、卵胞浆内单精子注射(ICSI)和圆形精子细胞注射(ROSI))。在体外模拟睾丸天然细胞外基质(ECM)的结构是实现完全体外精子发生和保留男性生育能力的一条明确途径。在此,一股新的技术创新浪潮正在兴起,即将再生医学策略应用于在补充了生物活性因子的天然或合成支架上进行细胞-组织培养。先进的生物工程系统的出现为通过发育功能性雄性生殖细胞来保留男性生育能力带来了新希望。迄今为止,针对体外精子发生的研究很少能产生足够数量的成熟配子。然而,目前已经有了大量关于在体外维持和成熟雄性生殖细胞所需条件的知识。本综述重点关注先进的生物工程方法,如应用于生殖系以通过体外精子发生来保留生育能力的微流控系统、生物制造的支架和3D器官培养。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验